Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Gossamer Bio (GOSS) Shares Issued (2022 - 2025)

Gossamer Bio's Shares Issued history spans 4 years, with the latest figure at -$938000.0 for Q4 2025.

  • For Q4 2025, Shares Issued fell 49.13% year-over-year to -$938000.0; the TTM value through Sep 2025 reached $309000.0, up 67.03%, while the annual FY2022 figure was $119.9 million, N/A changed from the prior year.
  • Shares Issued reached -$938000.0 in Q4 2025 per GOSS's latest filing, down from $566000.0 in the prior quarter.
  • In the past five years, Shares Issued ranged from a high of $118.2 million in Q4 2022 to a low of -$938000.0 in Q4 2025.
  • Average Shares Issued over 4 years is $9.2 million, with a median of $281000.0 recorded in 2024.
  • Peak YoY movement for Shares Issued: crashed 100.38% in 2023, then soared 264.94% in 2024.
  • A 4-year view of Shares Issued shows it stood at $118.2 million in 2022, then plummeted by 100.38% to -$444000.0 in 2023, then tumbled by 41.67% to -$629000.0 in 2024, then tumbled by 49.13% to -$938000.0 in 2025.
  • Per Business Quant, the three most recent readings for GOSS's Shares Issued are -$938000.0 (Q4 2025), $566000.0 (Q3 2025), and $240000.0 (Q2 2025).